ECON4615 Health Economics Spring 2005 Teachers: Tor Iversen (TI) – - 7 lectures/2 seminars Kari Eika (KE) –

Slides:



Advertisements
Similar presentations
PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
Advertisements

RESOURCE ALLOCATION & THE MARKET Demand, supply and the market Sources of failure in the market for health care The insurance system of funding health.
Vitality Institute Commission Forum Commission Recommendations The Vitality Institute's mission is to advance knowledge about the evolving science and.
Tor Iversen Health service provision Economic incentives and organization of the hospital sector I.
Tor Iversen Lecture 11: Economic incentives and the organization of private physician practice I.
Health and Human Sciences Economics and Health: a taster Masters in Public Health Key reference: McPake B., Kumaranayake, L. & Normand, C (2002) Health.
Code Blue Why are Costs so High? Chapters 8 through 14.
NonProfit Firm Introduction to Nonprofits
Understanding Health Economics Edina Sinanovic Health Economics Unit University of Cape Town May 2011 Copyright: Dr Edina Sinanovic.
Socio-Economic Implications of Health Disparities International Council on Social Welfare - ICSW Tuvia Horev Taub Center for Social Policy Studies in Israel.
American free enterprise
UNIVERZALIZATION OF SOCIAL PROTECTION IN HEALTH COVERAGE Daniel Titelman Chief, Development Studies Unit.
Can the English National Health Service learn from the Dutch reforms? Meeting the medium term challenge of the financing of health & aged care in England.
Part I: Basic Economics Tools
The Medical Hospice Benefit: The Effectiveness of Price Incentives in Health Care Policy Written By Vivian Hamilton, McGill University RAND Journal of.
C h a p t e r o n e Economics: Foundations and Models.
The relevance of Health Economics Research for the Health Policy Agenda Prof. Guillem López-Casasnovas Depart. de Economía Univ. Pompeu Fabra. Cataluña.
ECON 850 Health Economics Gilleskie Lecture 1: Introduction What is economics? What is health economics?
Getting Better Value for Money from Sweden’s Healthcare System By David Rae Presented by Allison Pokky.
Comparing health systems Week 19 Comparative Sociology.
THE PRESENT EXPERIENCE AND CHALLENGES BEFORE THE BULGARIAN HEALTH INSURANCE SYSTEM IN THE FIELD OF HOSPITAL CARE Jeni Nacheva Director of Department for.
TOPICS 1. FINANCIAL DECISIONS, INVESTMENT DECISIONS AND DIVIDEND DECISIONS 2. FINANCIAL MANAGEMENT PROCESS 3.PROFIT MAXIMIZATION AND WEALTH MAXIMIZATION.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Legal Framework for Social Medicine Rosanda Mulić October 2011
Cost-Containment, Medical Technology and Access to Care: A Comparative Analysis of Health Policy in the United States, the United Kingdom And Canada Emily.
Health care reform in the Netherlands – role of the employer
General presentation. 24 March 2003 | | ‹#› Overall objective Main objective To develop and improve preventive and health-promoting efforts and the services.
Lukas Steinmann Mexico 10. June 2008 To your health: diagnosing the state of healthcare and the global private medical insurance industry.
The Czech Health System – its Presence and Future Pavel Hroboň L.Dittrich.
Copyright McGraw-Hill/Irwin, 2002 The Health Care Industry Quality of Care Limited Access Increasing Demand for Health Care Role of Health Insurance.
Tor Iversen Health systems Literature (to be found in the compendium): Cutler, D.,2002. Equality, efficiency and market fundamentals: The.
3 August 2004 Public Health Practice III: FINANCING PUBLIC HEALTH REFORM Thomas E. Novotny MD MPH University of California San Francisco Institute for.
Svetlana Spassova, MD Ministry of Health, Bulgaria Chisinau
Elizabeth Docteur European Health Forum Gastein 7 October 2004 Towards High-Performing Health Systems: Challenges and Opportunities for Reform.
Copyright 2008 The McGraw-Hill Companies 21-1 The Health Care Industry Economic Implications of Rising Costs Why the Rapid Rise in Costs? Supply Factors.
Tor Iversen Lecture 8: Distributional considerations Reference on the reading list: Williams and Cookson.
CPB Netherlands Bureau for Economic Policy Analysis Why it may hurt to be insured the effects of capping coinsurance payments Ed Westerhout and Kees Folmer.
Health Care Financing: Insurance Health Economic Course Series: 3 of 12
Voluntary National Content Standards For Economics Presented by Joe Lockerd.
International Health Policy Program -Thailand NHA TEAM International Health Policy Program Draft report presentation for external peer review October 7,
Copyright McGraw-Hill/Irwin, 2005 The Health Care Industry Quality of Care Limited Access Increasing Demand for Health Care Role of Health Insurance.
Chapter 11 Investment, Productivity, and Growth. Investment and development Relationship between investment and development The two categories of investment,
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
Chapter 7 Physicians as Providers of Health Care.
LECTURE. PRODUCT QUALITY AND COMPETITIVENESS. PLAN OF THE LECTURE 1.The concept of quality products 2.The concept of competitive products.
Chapter 2: The Role of Economics
Market Failure 11 Farid Abolhassani.
Health Policy Analysis: Chapters 10, 11 and 14 Nutchanart Bunthumporn Beth Faiman.
Chapter 22 Health Care Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of.
SUPPLY SIDE POLICIES YOUSIF AL ZAROUNI. WHAT ARE SUPPLY SIDE POLICIES? Supply side policies are policies designed to improve the supply side potential.
Slides for Class 10: Traditional Economic Model That Depicts a Firm’s Output Problems With the Traditional Model The Implications These Problems Raise.
22 CHAPTER PUBLIC SECTOR ECONOMICS: The Role of Government in the American Economy Randall Holcombe Health Care.
Health Care Financing Health Economic Course Series
TRENDS AND CHALLENGES IN SOCIAL SECURITY: LESSONS FROM LATIN AMERICA Andras Uthoff Independent consultant. Ex Officer in Charge Social Development Division.
PUBLIC SECTOR ECONOMICS: The Role of Government in the American Economy Randall Holcombe 9 CHAPTER Supply and Demand in Political Markets.
Understanding the Integrated Resource Plan (IRP 2010 Rev 2)
An Economic Perspective
24 Health Care McGraw-Hill/Irwin
Lesson 1 Exploring the World of Business and Economics
HEALTH ECONOMICS BASICS
Cost of Production: Uses and Users
Lecture 8 Asymmetric Information: Adverse Selection
HCS 440 Competitive Success/snaptutorial.com
HCS 440 Education for Service-- snaptutorial.com.
HCS 440 Teaching Effectively-- snaptutorial.com
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
Of Financial Management Traditional View Modern View Objective of Financial Management Scope of Financial Management Relationship of Finance with other.
American free enterprise
Economic Foundations of Political Legitimacy
Presentation transcript:

ECON4615 Health Economics Spring 2005 Teachers: Tor Iversen (TI) – - 7 lectures/2 seminars Kari Eika (KE) – - 7 lectures/4 seminars Information about health economics research at UiO:

Course outline Lectures: 1.IntroductionTI: Health systemsTI: Demand for health and health servicesTI: 1.02, KE: 8.02, Demand for health insurance KE: 1.03, Distributional considerations KE: Health service provision Characteristics of demand and supply of health care KE: 5.04, Private physician practice TI: 19.04, HospitalsTI: 3.05, Seminars: 1.Health systems, prevention and cureKE: Demand for health and health servicesKE: 3.03, Demand for health insuranceKE: Equity/Health service provisionKE: Health service provisionTI: 28.04, Compulsory term paper: Questions available: Deadline for submission: 8.04 Examination: 30 May 9:00-12:00

Some reasons for economists’ interest in the health sector 1.Substantial and growing sector of the economy

Source: NOU 2003:1

Source: OECD 2001

Source: NOU 2003:1 2001: full-time equivalents per year growth: full-time equivalents

Development in technical efficiency and cost efficiency in Norwegian hospitals (1992 = 100). Source: Samdata Somatikk SINTEF Helse Rapport 1/04.

2. We need information of whether resources are properly used Do all health services have a positive impact on health? Are there services where the costs exceed the willingness to pay? –Insurance implies low co-payment and few incentives for patients to balance expected effect against social costs In public systems with global budgets: Are there services not being provided even if willingness to pay exceeds costs. Do organization, financing and payment systems influence to what extent health policy goals are expected to be fulfilled?

3.Markets imperfections may prevent social efficiency from being achieved External effects –Positive external effects of vaccination against infectious disease Patients have inferior information about the quality of health services: experience goods Irreversibility Asymmetric information related to health insurance –The insurer has imperfect information of health risks: Adverse selection –The insurer has imperfect information on preventive efforts: Ex ante moral hazard –The insurer has imperfect information of necessary treatment: Ex post moral hazard

4. Public sector allocation has its own challenges The government as a single provider of compulsory insurance What kind of health services should be provided by the public sector? What kind of patients should have priority? –The most severly ill? –Those for whom treatment has the greatest health effect? –Those with greatest health effect per krone used?

Prioritizing services and groups of patients according to explicit goals The importance of the content of the criteria for priority-setting Consider an example

Alternative rules (criteria) for making priorities: A: Priority according to the seriousness (prospects without the treatment) of the disease Prioritize according to increasing survival without treatment B: Priority according to treatment effect Prioritize according to difference in survival with treatment and without treatment, such that the group with the greatest difference is given first priority. C: Maximize total health within the resource constraint Prioritize according to increasing cost per saved life, such that the group with lowest cost per saved life is given first priority. D: Priority according to the seriousness of the disease constrained by an upper limit on cost per saved life. E: Maximize total health constrained by a lower limit on the seriousness of disease

The importance of criteria for prioritizing the three treatments

Some implications: Optimal priority-setting depends on the aims that the health sector is expected to pursue It is possible to obtain a considerable total health gain by prioritizing treatments with modest effect given that they are sufficiently inexpensive Criteria C and E is at a disadvantage for patients who, because of some reason, do not manage to get much health out of the health services The cost of treatment relative to other treatments should not influence priority according to criteria A and B. The introduction of cost saving technologies should influence priorities according to criterion C (and possibly D and E), but not according to criteria A and B Cost- benefit analysis are relevant for priority decisions only according to criteria C, D and E Hence, if you are in favor of criteria A or B, it is inconsistent simultaneously to argue that cost-benefit analysis should have an increased role as a means to allocating resources within the health sector Economic incentives should have no effect on priorities according to criteria A and B

In recent legislation in many countries it is stated that there should be a reasonable relation between the potential health effect of a treatment and its cost. But what is a reasonable relation? How should the effect of a treatment be documented? How should health effects be valuated allowing for comparison between groups of patients? Some treatments save life while others mainly improves quality of life Calculation of costs in missing or non existent markets and prices

Further questions: What is the optimal level of patient copayment for health services? Should copayments be differentiated across services? Does type of payment system have any effect on decisions made by health service providers? How do health service providers respond to the characteristics of the health care market? What is the optimal payment system for health service providers? How should provision of health services be organized? How should insurance be organized? Public or private? Compulsory or voluntary?

Important tasks for economists in planning and managing the health care sector Hospitals, regional health enterprises, municipality and county level of government, ministry of health, ministry of finance, medicine agency, pharmaceutical industry, national and international organizations Analysis of costs and benefits of specific diagnostics and treatments To give advice concerning institutional setups: organization and payment system Economics still controversial in the health sector – professional self governance has been the tradition. Physicians know best. A strong tendency in the direction of economic thinking having a more influential role in the managing of the health sector

About the reading list 1.Introduction OECD, Health at a glance – OECD indicators 2003 (OECD, Paris). OECD, Towards high-performing health systems (OECD, Paris). 2.Health systems Cutler, D.,2002. Equality, efficiency and market fundamentals: The dynamics of international medical-care reform. Journal of Economic Literature 40, Kornai, J. and Eggleston, K., Welfare, choice and solidarity in transition (Cambridge University Press, Cambridge) Demand for health and health services Grossmann, M., 2000, The Human Capital Model. In A. J. Culyer and J.P. Newhouse, eds., Handbook of Health Economics (Elsevier Science B.V., Amsterdam) Hey, J. D. and M. S. Patel, 1983, Prevention and cure? Or: Is an ounce of prevention better than a pound of cure? Journal of Health Economics 2, Health insurance Rees R, 1989, Uncertainty, information and insurance, in J. D. Hey, ed., Current Issues in Microeconomics (Palgrave Macmillan, London). Arrow, K. E., 1963, Uncertainty and the welfare economics of medical care, American Economic Review 53, 941 ‑ 973.

5.Distributional considerations Williams, A., Cookson, R., Equity in Health. In A.J.Culyer and J.P. Newhouse (ed.): Handbook of Health Economics, Volume 1B (Elsevier Science, Amsterdam) Health service provision Biørn, E., Hagen, T. P., Iversen, T., Magnussen, J., The Effect of Activity- Based Financing on Hospital Efficiency: A Panel Data Analysis of DEA Efficiency Scores 1992–2000. Health Care Management Science 6, 271–283. Chalkley, M., Malcomson, J. M., Government purchasing of health services. In A.J.Culyer and J.P. Newhouse (ed.): Handbook of Health Economics Volume 1A, (Elsevier Science, Amsterdam) Eika, K Low Quality-effective Demand, Memorandum 36/2003. Department of Economics, University of Oslo. Iversen, T., The effects of a patient shortage on general practitioners’ future income and list of patients. Journal of Health Economics 23, McGuire, T. G., Physician agency. In A. J. Culyer and J. P. Newhouse: Handbook of Health Economics, Volume 1A (Elsevier Science, Amsterdam) Norwegian speaking students will find useful information about the Norwegian health care system in: NOU:2003:1. Behovsbasert finansiering av spesialisthelsetjenesten (Statens forvaltningstjeneste, Oslo).